AORT
Artivion, Inc.
Price Chart
Latest Quote
$20.12
-0.72 (-3.45%)
Current Price
| Previous Close | $20.84 |
| Open | $20.89 |
| Day High | $21.34 |
| Day Low | $20.00 |
| Volume | 554,932 |
Stock Information
| Shares Outstanding | 48.54M |
| Total Debt | $258.16M |
| Cash Equivalents | $55.76M |
| Revenue | $458.69M |
| Net Income | $11.68M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $976.69M |
| P/E Ratio | 80.48 |
| EPS (TTM) | $0.25 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.18B |
| Sales | $458.69M |
| Income | $11.68M |
| Book/sh | $9.29 |
| Cash/sh | $1.15 |
| Employees | 2K |
Financial Ratios
| Quick Ratio | 1.74 |
| Current Ratio | 3.86 |
| Debt/Eq | 57.31 |
Returns & Margins
| ROA | 2.84% |
| ROE | 3.14% |
| Gross Margin | 64.55% |
| Operating Margin | 5.18% |
| Profit Margin | 2.55% |
Ownership
| Insider Ownership | 4.63% |
| Institutional Ownership | 93.47% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 26.02 |
| PEG | 643.75 |
| P/S | 2.13 |
| P/B | 2.17 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $42.00 |
Technical Indicators
| SMA20 | $22.42 |
| SMA50 | $30.73 |
| SMA200 | $39.37 |
| RSI | 31.42 |
| ATR | 1.1114 |
| Shares Float | 46.00M |
| Short Float | 4.81% |
| Short Ratio | 2.77 |
| Volatility | 1.26 |
| Rel Volume | 0.55 |
Performance History
| Week | -9.33% |
| Month | -42.07% |
| Quarter | -45.68% |
| 6 Months | -55.76% |
| YTD | -54.75% |
| Year | -29.80% |
| 3 Years | +34.31% |
| 5 Years | -30.16% |
| 10 Years | +71.23% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $20.12 | 554,900 |
| 2026-06-04 | $20.84 | 1,010,400 |
| 2026-06-03 | $20.58 | 644,300 |
| 2026-06-02 | $20.42 | 662,100 |
| 2026-06-01 | $21.05 | 807,400 |
| 2026-05-29 | $22.19 | 700,100 |
| 2026-05-28 | $22.57 | 438,100 |
| 2026-05-27 | $22.76 | 487,100 |
| 2026-05-26 | $23.19 | 534,100 |
| 2026-05-22 | $22.46 | 651,600 |
| 2026-05-21 | $22.77 | 638,600 |
| 2026-05-20 | $22.67 | 880,300 |
| 2026-05-19 | $22.73 | 761,300 |
| 2026-05-18 | $23.76 | 1,019,700 |
| 2026-05-15 | $22.77 | 863,900 |
| 2026-05-14 | $22.93 | 758,500 |
| 2026-05-13 | $22.23 | 796,300 |
| 2026-05-12 | $23.10 | 953,800 |
| 2026-05-11 | $23.81 | 1,813,500 |
| 2026-05-08 | $25.41 | 5,137,000 |
| 2026-05-07 | $35.42 | 902,200 |
| 2026-05-06 | $34.73 | 516,500 |
About Artivion, Inc.
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system; NEXUS TRE, a custom-made three branch graft; E-vita thoracic 3G, a stent graft system; E-xtra Design Engineering, a range of stent graft systems for the treatment of aortic vascular diseases, such as TAAA and Artivex; E-nside, a multibranch stent graft system; E-tegra, an AAA stent graft system; E-ventus BX and Tuva BX balloon-expandable peripheral stent grafts; and E-liac, a stent graft used to treat aneurysmal iliac arteries. In addition, the company offers synthetic vascular grafts that are used in open aortic and peripheral vascular surgical procedures; BioGlue, a surgical sealant; CryoValve SG pulmonary heart valve; CryoPatch SG pulmonary cardiac patch; SynerGraft, a decellularization technology; vascular preservation services; and PhotoFix, a bovine pericardial patch fixated. It markets its products and preservation services primarily to physicians through a direct sales team to hospitals and other healthcare facilities. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.
đ° Latest News
3 Healthcare Stocks We Keep Off Our Radar
StockStory âĸ 2026-05-28T16:30:27Z
Artivion (NYSE:AORT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Simply Wall St. âĸ 2026-05-20T12:29:03Z
Artivion Bets On Full Aortic Arch Suite After Endospan Deal
Simply Wall St. âĸ 2026-05-19T04:36:32Z
Artivion closes Endospan buyout to acquire recently approved heart device
MedTech Dive âĸ 2026-05-19T03:58:30Z
Artivion strengthens aortic arch portfolio with $135m Endospan acquisition
Medical Device Network âĸ 2026-05-18T16:43:24Z
Crafting title options within editorial guidelines An ETF Shop Just Made a Beaten-Down Medtech Its Top Holding
Motley Fool âĸ 2026-05-17T20:51:23Z
5 Insightful Analyst Questions From Artivionâs Q1 Earnings Call
StockStory âĸ 2026-05-17T15:56:55Z
Why Artivion (AORT) Stock Is Falling Today
StockStory âĸ 2026-05-12T19:16:55Z
AORT Q1 Deep Dive: Guidance Reset and Product Launches Shape 2026 Outlook
StockStory âĸ 2026-05-12T02:36:55Z
How Artivionâs Softer 2026 Outlook After Q1 Profit Turn Will Impact Artivion (AORT) Investors
Simply Wall St. âĸ 2026-05-11T04:21:52Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $157,103,000 | $139,756,000 | $124,828,000 | $111,266,000 |
| Cost Of Revenue | $157,103,000 | $139,756,000 | $124,828,000 | $111,266,000 |
| Total Revenue | $441,330,000 | $388,537,000 | $354,004,000 | $313,789,000 |
| Operating Revenue | $441,330,000 | $388,537,000 | $354,004,000 | $313,789,000 |
| Expenses | ||||
| Interest Expense | $26,582,000 | $34,277,000 | $25,299,000 | $18,224,000 |
| Total Expenses | $414,585,000 | $349,663,000 | $362,512,000 | $307,588,000 |
| Other Income Expense | $13,854,000 | $-13,578,000 | $11,144,000 | $-3,108,000 |
| Other Non Operating Income Expenses | $9,518,000 | $-9,909,000 | $-3,106,000 | $-3,108,000 |
| Net Non Operating Interest Income Expense | $-25,819,000 | $-32,810,000 | $-24,222,000 | $-18,077,000 |
| Interest Expense Non Operating | $26,582,000 | $34,277,000 | $25,299,000 | $18,224,000 |
| Operating Expense | $257,482,000 | $209,907,000 | $237,684,000 | $196,322,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $9,768,000 | $-13,359,000 | $-30,690,000 | $-19,192,000 |
| Net Interest Income | $-25,819,000 | $-32,810,000 | $-24,222,000 | $-18,077,000 |
| Interest Income | $763,000 | $1,467,000 | $1,077,000 | $147,000 |
| Normalized Income | $6,901,904 | $-10,460,490 | $-41,947,500 | $-19,192,000 |
| Net Income From Continuing And Discontinued Operation | $9,768,000 | $-13,359,000 | $-30,690,000 | $-19,192,000 |
| Total Operating Income As Reported | $33,745,000 | $38,874,000 | $5,742,000 | $6,201,000 |
| Net Income Common Stockholders | $9,757,000 | $-13,335,000 | $-30,567,000 | $-19,094,000 |
| Net Income | $9,768,000 | $-13,359,000 | $-30,690,000 | $-19,192,000 |
| Net Income Including Noncontrolling Interests | $9,768,000 | $-13,359,000 | $-30,690,000 | $-19,192,000 |
| Net Income Continuous Operations | $9,768,000 | $-13,359,000 | $-30,690,000 | $-19,192,000 |
| Pretax Income | $14,780,000 | $-7,514,000 | $-21,586,000 | $-14,984,000 |
| Special Income Charges | $4,336,000 | $-3,669,000 | $14,250,000 | $0 |
| Interest Income Non Operating | $763,000 | $1,467,000 | $1,077,000 | $147,000 |
| Operating Income | $26,745,000 | $38,874,000 | $-8,508,000 | $6,201,000 |
| Gross Profit | $284,227,000 | $248,781,000 | $229,176,000 | $202,523,000 |
| Per Share | ||||
| Diluted EPS | $0.21 | $-0.32 | $-0.75 | $-0.48 |
| Basic EPS | $0.22 | $-0.32 | $-0.75 | $-0.48 |
| Other | ||||
| Tax Effect Of Unusual Items | $1,469,904 | $-770,490 | $2,992,500 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $59,484,000 | $54,637,000 | $12,539,000 | $25,682,000 |
| Total Unusual Items | $4,336,000 | $-3,669,000 | $14,250,000 | $0 |
| Total Unusual Items Excluding Goodwill | $4,336,000 | $-3,669,000 | $14,250,000 | $0 |
| Reconciled Depreciation | $22,458,000 | $24,205,000 | $23,076,000 | $22,442,000 |
| EBITDA (Bullshit earnings) | $63,820,000 | $50,968,000 | $26,789,000 | $25,682,000 |
| EBIT | $41,362,000 | $26,763,000 | $3,713,000 | $3,240,000 |
| Diluted Average Shares | $47,162,000 | $41,676,000 | $40,743,000 | $40,032,000 |
| Basic Average Shares | $45,335,000 | $41,676,000 | $40,743,000 | $40,032,000 |
| Diluted NI Availto Com Stockholders | $9,757,000 | $-13,335,000 | $-30,567,000 | $-19,094,000 |
| Otherunder Preferred Stock Dividend | $11,000 | $-24,000 | $-123,000 | $-98,000 |
| Tax Provision | $5,012,000 | $5,845,000 | $9,104,000 | $4,208,000 |
| Gain On Sale Of Ppe | $7,000,000 | $0 | $14,250,000 | $0 |
| Other Special Charges | $2,664,000 | $3,669,000 | - | - |
| Research And Development | $30,991,000 | $28,452,000 | $28,707,000 | $38,879,000 |
| Selling General And Administration | $226,491,000 | $181,455,000 | $208,977,000 | $157,443,000 |
Fetched: 2026-06-05
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $37,646,000 | $-121,141,000 | $-137,788,000 | $-141,949,000 |
| Total Assets | $884,796,000 | $789,101,000 | $792,397,000 | $762,798,000 |
| Total Non Current Assets | $526,714,000 | $499,021,000 | $511,729,000 | $515,464,000 |
| Other Non Current Assets | $15,238,000 | $24,483,000 | $8,894,000 | $7,339,000 |
| Non Current Deferred Assets | $1,201,000 | $1,068,000 | $1,087,000 | $1,314,000 |
| Non Current Deferred Taxes Assets | $1,201,000 | $1,068,000 | $1,087,000 | $1,314,000 |
| Goodwill And Other Intangible Assets | $410,586,000 | $397,341,000 | $419,568,000 | $426,278,000 |
| Other Intangible Assets | $156,495,000 | $156,383,000 | $172,231,000 | $182,647,000 |
| Current Assets | $358,082,000 | $290,080,000 | $280,668,000 | $247,334,000 |
| Other Current Assets | $42,537,000 | $19,257,000 | $15,810,000 | $17,550,000 |
| Current Deferred Assets | $54,531,000 | $51,701,000 | $49,804,000 | $46,371,000 |
| Inventory | $92,427,000 | $79,766,000 | $81,976,000 | $74,478,000 |
| Receivables | $103,679,000 | $85,893,000 | $74,138,000 | $69,584,000 |
| Other Receivables | $13,921,000 | $6,431,000 | $2,342,000 | $7,764,000 |
| Accounts Receivable | $89,758,000 | $79,462,000 | $71,796,000 | $61,820,000 |
| Cash Cash Equivalents And Short Term Investments | $64,908,000 | $53,463,000 | $58,940,000 | $39,351,000 |
| Cash And Cash Equivalents | $64,908,000 | $53,463,000 | $58,940,000 | $39,351,000 |
| Allowance For Doubtful Accounts Receivable | - | - | - | $-1,300,000 |
| Gross Accounts Receivable | - | - | - | $63,120,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $150,206,000 | $260,884,000 | $248,042,000 | $268,756,000 |
| Total Debt | $257,614,000 | $362,258,000 | $358,341,000 | $356,829,000 |
| Long Term Debt And Capital Lease Obligation | $252,239,000 | $356,973,000 | $352,913,000 | $351,400,000 |
| Long Term Debt | $215,114,000 | $314,152,000 | $305,531,000 | $306,499,000 |
| Current Debt And Capital Lease Obligation | $5,375,000 | $5,285,000 | $5,428,000 | $5,429,000 |
| Current Debt | - | $195,000 | $1,451,000 | $1,608,000 |
| Other Current Borrowings | - | $195,000 | $1,451,000 | $1,608,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $436,564,000 | $512,901,000 | $510,617,000 | $478,469,000 |
| Total Non Current Liabilities Net Minority Interest | $335,008,000 | $446,078,000 | $452,755,000 | $428,794,000 |
| Other Non Current Liabilities | $48,997,000 | $60,945,000 | $71,231,000 | $47,427,000 |
| Non Current Deferred Liabilities | $33,772,000 | $28,160,000 | $28,611,000 | $29,967,000 |
| Non Current Deferred Taxes Liabilities | $24,308,000 | $20,183,000 | $21,851,000 | $24,499,000 |
| Current Liabilities | $101,556,000 | $66,823,000 | $57,862,000 | $49,675,000 |
| Other Current Liabilities | $25,468,000 | $583,000 | $2,390,000 | $1,312,000 |
| Payables And Accrued Expenses | $48,229,000 | $42,613,000 | $31,329,000 | $29,124,000 |
| Interest Payable | $4,815,000 | $8,170,000 | $2,283,000 | - |
| Payables | $23,531,000 | $20,905,000 | $17,158,000 | $14,639,000 |
| Total Tax Payable | $7,489,000 | $2,934,000 | $3,840,000 | $2,635,000 |
| Accounts Payable | $16,042,000 | $17,971,000 | $13,318,000 | $12,004,000 |
| Equity | ||||
| Common Stock Equity | $448,232,000 | $276,200,000 | $281,780,000 | $284,329,000 |
| Total Equity Gross Minority Interest | $448,232,000 | $276,200,000 | $281,780,000 | $284,329,000 |
| Stockholders Equity | $448,232,000 | $276,200,000 | $281,780,000 | $284,329,000 |
| Gains Losses Not Affecting Retained Earnings | $-2,719,000 | $-24,927,000 | $-12,010,000 | $-21,609,000 |
| Other Equity Adjustments | $-2,719,000 | $-24,927,000 | $-12,010,000 | $-21,609,000 |
| Retained Earnings | $-51,498,000 | $-61,266,000 | $-47,907,000 | $-17,217,000 |
| Other | ||||
| Treasury Shares Number | $1,487,000 | $1,487,000 | $1,487,000 | $1,487,000 |
| Ordinary Shares Number | $47,843,000 | $41,945,000 | $41,082,000 | $40,343,000 |
| Share Issued | $49,330,000 | $43,432,000 | $42,569,000 | $41,830,000 |
| Tangible Book Value | $37,646,000 | $-121,141,000 | $-137,788,000 | $-141,949,000 |
| Invested Capital | $663,346,000 | $590,547,000 | $588,762,000 | $592,436,000 |
| Working Capital | $256,526,000 | $223,257,000 | $222,806,000 | $197,659,000 |
| Capital Lease Obligations | $42,500,000 | $47,911,000 | $51,359,000 | $48,722,000 |
| Total Capitalization | $663,346,000 | $590,352,000 | $587,311,000 | $590,828,000 |
| Treasury Stock | $14,648,000 | $14,648,000 | $14,648,000 | $14,648,000 |
| Additional Paid In Capital | $516,604,000 | $376,607,000 | $355,919,000 | $337,385,000 |
| Capital Stock | $493,000 | $434,000 | $426,000 | $418,000 |
| Common Stock | $493,000 | $434,000 | $426,000 | $418,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $37,125,000 | $42,821,000 | $47,382,000 | $44,901,000 |
| Current Capital Lease Obligation | $5,375,000 | $5,090,000 | $3,977,000 | $3,821,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $22,484,000 | $18,342,000 | $18,715,000 | $13,810,000 |
| Current Accrued Expenses | $24,698,000 | $21,708,000 | $14,171,000 | $14,485,000 |
| Goodwill | $254,091,000 | $240,958,000 | $247,337,000 | $243,631,000 |
| Net PPE | $99,689,000 | $76,129,000 | $82,180,000 | $80,533,000 |
| Accumulated Depreciation | $-97,844,000 | $-89,168,000 | $-84,922,000 | $-88,338,000 |
| Gross PPE | $197,533,000 | $165,297,000 | $167,102,000 | $168,871,000 |
| Leases | $53,596,000 | $51,213,000 | $49,107,000 | $47,384,000 |
| Other Properties | $34,701,000 | $39,726,000 | $43,822,000 | $41,859,000 |
| Machinery Furniture Equipment | $89,301,000 | $74,358,000 | $74,173,000 | $79,628,000 |
| Buildings And Improvements | $19,935,000 | $0 | - | - |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $38,939,000 | $30,545,000 | $32,382,000 | $27,287,000 |
| Work In Process | $17,133,000 | $13,926,000 | $12,687,000 | $10,476,000 |
| Raw Materials | $36,355,000 | $35,295,000 | $36,907,000 | $36,715,000 |
Fetched: 2026-06-05
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $839,000 | $11,048,000 | $9,073,000 | $-15,868,000 |
| Operating Activities | ||||
| Operating Cash Flow | $39,880,000 | $22,236,000 | $18,825,000 | $-5,153,000 |
| Cash Flow From Continuing Operating Activities | $39,880,000 | $22,236,000 | $18,825,000 | $-5,153,000 |
| Operating Gains Losses | $-4,336,000 | $3,669,000 | $-14,250,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-39,041,000 | $-11,188,000 | $-9,752,000 | $-10,715,000 |
| Investing Cash Flow | $-42,041,000 | $-28,188,000 | $-502,000 | $-10,715,000 |
| Cash Flow From Continuing Investing Activities | $-42,041,000 | $-28,188,000 | $-502,000 | $-10,715,000 |
| Net Other Investing Changes | $-3,000,000 | $-17,000,000 | $9,250,000 | $-1,699,000 |
| Capital Expenditure Reported | $-39,041,000 | $-11,188,000 | $-9,752,000 | $-10,715,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $0 | $-559,000 | $-1,795,000 |
| Financing Cash Flow | $11,282,000 | $2,203,000 | $865,000 | $-1,639,000 |
| Cash Flow From Continuing Financing Activities | $11,282,000 | $2,203,000 | $865,000 | $-1,639,000 |
| Net Other Financing Charges | $668,000 | $-3,167,000 | $2,772,000 | $-459,000 |
| Net Common Stock Issuance | $0 | $0 | $-559,000 | $-1,795,000 |
| Other | ||||
| Repayment Of Debt | $-2,460,000 | $-212,858,000 | $-5,303,000 | $-2,753,000 |
| Issuance Of Debt | $0 | $212,500,000 | $0 | $0 |
| End Cash Position | $64,908,000 | $53,463,000 | $58,940,000 | $39,351,000 |
| Beginning Cash Position | $53,463,000 | $58,940,000 | $39,351,000 | $55,010,000 |
| Effect Of Exchange Rate Changes | $2,324,000 | $-1,728,000 | $401,000 | $1,848,000 |
| Changes In Cash | $9,121,000 | $-3,749,000 | $19,188,000 | $-17,507,000 |
| Proceeds From Stock Option Exercised | $13,074,000 | $5,728,000 | $3,955,000 | $3,368,000 |
| Common Stock Payments | $0 | $0 | $-559,000 | $-1,795,000 |
| Net Issuance Payments Of Debt | $-2,460,000 | $-358,000 | $-5,303,000 | $-2,753,000 |
| Net Short Term Debt Issuance | $-2,250,000 | $-1,027,000 | $-2,531,000 | $0 |
| Short Term Debt Payments | $-2,250,000 | $-1,027,000 | $-2,531,000 | $0 |
| Net Long Term Debt Issuance | $-210,000 | $669,000 | $-2,772,000 | $-2,753,000 |
| Long Term Debt Payments | $-210,000 | $-211,831,000 | $-2,772,000 | $-2,753,000 |
| Long Term Debt Issuance | $0 | $212,500,000 | $0 | $0 |
| Change In Working Capital | $-22,161,000 | $-17,243,000 | $-13,380,000 | $-23,170,000 |
| Change In Payables And Accrued Expense | $2,183,000 | $9,498,000 | $4,495,000 | $808,000 |
| Change In Payable | $2,183,000 | $9,498,000 | $4,495,000 | $808,000 |
| Change In Account Payable | $2,183,000 | $9,498,000 | $4,495,000 | $808,000 |
| Change In Prepaid Assets | $-1,798,000 | $-5,209,000 | $535,000 | $-2,234,000 |
| Change In Inventory | $-15,277,000 | $-6,137,000 | $-14,360,000 | $-8,404,000 |
| Change In Receivables | $-7,269,000 | $-15,395,000 | $-4,050,000 | $-13,340,000 |
| Other Non Cash Items | $4,829,000 | $7,799,000 | $36,247,000 | $-234,000 |
| Stock Based Compensation | $24,385,000 | $14,242,000 | $14,422,000 | $12,344,000 |
| Asset Impairment Charge | $4,900,000 | $4,434,000 | $4,785,000 | $4,374,000 |
| Deferred Tax | $37,000 | $-1,511,000 | $-1,385,000 | $-1,717,000 |
| Deferred Income Tax | $37,000 | $-1,511,000 | $-1,385,000 | $-1,717,000 |
| Depreciation Amortization Depletion | $22,458,000 | $24,205,000 | $23,076,000 | $22,442,000 |
| Depreciation And Amortization | $22,458,000 | $24,205,000 | $23,076,000 | $22,442,000 |
| Net Income From Continuing Operations | $9,768,000 | $-13,359,000 | $-30,690,000 | $-19,192,000 |
| Net Business Purchase And Sale | - | - | $-5,000,000 | $0 |
| Purchase Of Business | - | - | $-5,000,000 | $0 |
| Short Term Debt Issuance | - | - | - | $0 |
| Net Investment Purchase And Sale | - | - | - | $0 |
| Sale Of Investment | - | - | - | $0 |
| Net Intangibles Purchase And Sale | - | - | - | $-1,699,000 |
| Purchase Of Intangibles | - | - | - | $-1,699,000 |
Fetched: 2026-06-05